TAFI
- 1 March 1999
- journal article
- Published by Elsevier in Fibrinolysis and Proteolysis
- Vol. 13 (2) , 72-77
- https://doi.org/10.1016/s0268-9499(99)90082-6
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Activation of Thrombin-activable Fibrinolysis Inhibitor Requires Epidermal Growth Factor-like Domain 3 of Thrombomodulin and Is Inhibited Competitively by Protein CJournal of Biological Chemistry, 1998
- Plasma and Recombinant Thrombin-activable Fibrinolysis Inhibitor (TAFI) and Activated TAFI Compared with Respect to Glycosylation, Thrombin/Thrombomodulin-dependent Activation, Thermal Stability, and Enzymatic PropertiesPublished by Elsevier ,1998
- On the Mechanism of the Antifibrinolytic Activity of Plasma Carboxypeptidase BJournal of Biological Chemistry, 1997
- The Gene for Human Carboxypeptidase U (CPU)— A Proposed Novel Regulator of Plasminogen Activation— Maps to 13q14.11Genomics, 1996
- TAFI, or Plasma Procarboxypeptidase B, Couples the Coagulation and Fibrinolytic Cascades through the Thrombin-Thrombomodulin ComplexPublished by Elsevier ,1996
- Purification and Characterization of TAFI, a Thrombin-activable Fibrinolysis InhibitorJournal of Biological Chemistry, 1995
- Activation and Characterization of Procarboxypeptidase B from Human PlasmaBiochemistry, 1995
- Purification and characterization of a new arginine carboxypeptidase in human serumBiochimica et Biophysica Acta (BBA) - General Subjects, 1990
- The cofactor role of protein S in the acceleration of whole blood clot lysis by activated protein C in vitroBlood, 1986
- Whole blood clot lysis: In vitro modulation by activated protein CThrombosis Research, 1985